|Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer|
FJ Couch, SN Hart, P Sharma, AE Toland, X Wang, P Miron, JE Olson, ...
Journal of clinical oncology 33 (4), 304, 2015
|Prediction of breast cancer risk based on profiling with common genetic variants|
N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ...
JNCI: Journal of the National Cancer Institute 107 (5), 2015
|Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing|
H Shimelis, H LaDuca, C Hu, SN Hart, J Na, A Thomas, M Akinhanmi, ...
JNCI: Journal of the National Cancer Institute 110 (8), 855-862, 2018
|Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis|
CB Ambrosone, S Kropp, J Yang, S Yao, PG Shields, J Chang-Claude
Cancer Epidemiology and Prevention Biomarkers 17 (1), 15-26, 2008
|Vegetable-derived isothiocyanates: anti-proliferative activity and mechanism of action|
Y Zhang, S Yao, J Li
Proceedings of the Nutrition Society 65 (1), 68-75, 2006
|Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study|
S Yao, LE Sucheston, AE Millen, CS Johnson, DL Trump, MK Nesline, ...
PloS one 6 (2), e17251, 2011
|Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study|
S Yao, ML Kwan, IJ Ergas, JM Roh, TYD Cheng, CC Hong, SE McCann, ...
JAMA oncology 3 (3), 351-357, 2017
|Conducting molecular epidemiological research in the age of HIPAA: a multi-institutional case-control study of breast cancer in African-American and European-American women|
CB Ambrosone, GL Ciupak, EV Bandera, L Jandorf, DH Bovbjerg, ...
Journal of oncology 2009, 2009
|Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study|
S Yao, G Zirpoli, DH Bovbjerg, L Jandorf, CC Hong, H Zhao, ...
Breast Cancer Research 14 (2), 1-13, 2012
|Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer|
FJ Couch, KB Kuchenbaecker, K Michailidou, GA Mendoza-Fandino, ...
Nature communications 7 (1), 1-13, 2016
|Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study|
CB Ambrosone, G Zirpoli, M Ruszczyk, J Shankar, CC Hong, D McIlwain, ...
Cancer Causes & Control 25 (2), 259-265, 2014
|Circulating miR-148b and miR-133a as biomarkers for breast cancer detection|
J Shen, Q Hu, M Schrauder, L Yan, D Wang, L Medico, Y Guo, S Yao, ...
Oncotarget 5 (14), 5284, 2014
|Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women|
S Yao, CB Ambrosone
The Journal of steroid biochemistry and molecular biology 136, 337-341, 2013
|Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)|
LE Sucheston, H Zhao, S Yao, G Zirpoli, S Liu, WE Barlow, HCF Moore, ...
Breast cancer research and treatment 130 (3), 993-1002, 2011
|Gene polymorphisms in cyclophosphamide metabolism pathway, treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer|
S Yao, WE Barlow, KS Albain, JY Choi, H Zhao, RB Livingston, W Davis, ...
Clinical Cancer Research 16 (24), 6169-6176, 2010
|Important role of menarche in development of estrogen receptor–negative breast cancer in African American women|
CB Ambrosone, G Zirpoli, CC Hong, S Yao, MA Troester, EV Bandera, ...
JNCI: Journal of the National Cancer Institute 107 (9), 2015
|Tumor expression of vitamin D receptor and breast cancer histopathological characteristics and prognosis|
J Al-Azhri, Y Zhang, W Bshara, G Zirpoli, SE McCann, T Khoury, ...
Clinical Cancer Research 23 (1), 97-103, 2017
|Genetic predisposition to ductal carcinoma in situ of the breast|
C Petridis, MN Brook, V Shah, K Kohut, P Gorman, M Caneppele, D Levi, ...
Breast cancer research 18 (1), 1-15, 2016
|Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study|
S Yao, C Till, AR Kristal, PJ Goodman, AW Hsing, CM Tangen, EA Platz, ...
Cancer Causes & Control 22 (8), 1121-1131, 2011
|Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers|
CC Hong, S Yao, SE McCann, RY Dolnick, PK Wallace, Z Gong, L Quan, ...
Breast cancer research and treatment 139 (2), 477-488, 2013